What are the opening hours?

Monday 9:15am - 6:15pm Tuesday 9:15am - 6:15pm Wednesday 9:15am - 6:15pm Thursday 9:15am - 6:15pm Friday 9:15am - 6:15pm

Sailifesciences, DS-7, IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Medchal-Malkajgiri District, Turkapalli (2026)

29/01/2026

We've entered into a strategic collaboration with Mabtech, a global life science tools company specializing in advanced immunoassays, to establish our Boston laboratory as a co-marketed US ex*****on and demonstration hub for the Mabtech EYRA™ platform.

Under this collaboration, Sai and Mabtech will jointly deliver advanced immunology assay services — including high-sensitivity multiplex cytokine and phenotyping workflows — powered by the EYRA platform installed at Sai’s Boston discovery site. This initiative accelerates access to next-generation immune profiling capabilities for biopharma and biotech companies working in immuno-oncology, vaccines, inflammation, and cellular therapy.

Read full story here: https://www.sailife.com/mabtech-and-sai-life-sciences-announce-strategic-collaboration-to-advance-immunology-research-with-eyra-platform-at-sai-boston-site/

27/01/2026

Sai Life Sciences will be at BioAsia 2026 (Feb 17–18, Hyderabad), the premier life sciences and health-tech event hosted by the Government of Telangana, bringing together global leaders under the theme 'TechBio Unleashed: AI, Automation & the Biology Revolution.'

We are one of the fastest growing contract research, development, and manufacturing organization (CRDMO), working with innovator pharma and biotech companies to speed up the journey from discovery to commercialization.

With our roots in Hyderabad, we have grown alongside the city’s life sciences cluster—drawing strength from its skilled workforce and research ecosystem while actively helping build capabilities that serve the global industry. Come meet our team to explore how we can collaborate to advance the next generation of medicines.

01/01/2026

This New Year’s Day, we’re sharing an initiative that has been quietly taking shape over the past few weeks.

Story Hour’ is a weekly volunteering initiative where our Saimers read with children at government schools, fostering connection, curiosity, and a love for learning.

In partnership with Pustakaar, these sessions bring stories to life through read-alouds and simple activities that spark imagination, build language skills, and make reading joyful. It’s a small commitment of time—but one that opens up big worlds for young minds.

Story Hour is part of Sai Cares, our employee volunteering initiative that brings colleagues together to give back through time, care, and shared purpose.

Here’s to a year of learning, kindness, and stories that stay with us.

19/12/2025

We have released our Sustainability Report for 2024–25. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 and the Sustainability Accounting Standards Board (SASB) standards, this sixth edition is presented under the theme “Driving climate action, deepening stakeholder trust.”

During the year, we advanced our internally defined Sustainable Development Goals (SDGs), outlining a clear roadmap to meet our sustainability commitments by March 31, 2027. The report highlights progress in greenhouse gas reduction, a significant increase in renewable energy usage—with 96% of our API manufacturing unit in Bidar powered by renewables—and reductions in specific water consumption across facilities.

Read the Sustainability Report here: https://www.sailife.com/sustainability-report/2025/

18/12/2025

One year ago, a bell rang.

On December 18, 2024, we marked the beginning of a new chapter for Sai Life Sciences as a listed company.

Our arrival on the public stage has coincided with a significant period of churn and change in the global pharmaceutical ecosystem. Innovation cycles have accelerated. New modalities are taking center stage. Supply chains continue to recalibrate. Across the industry, the focus has sharpened on ex*****on, resilience, and long-term partnerships—particularly across CRO and CDMO models that enable scale, speed, and scientific depth.

Against this backdrop, the year for us has been about quiet ex*****on—strengthening the foundations needed to support complex science at scale. We have expanded our scientific teams, increased operating scale across our laboratories and plant, and deepened capabilities aligned to the evolving needs of global pharma and biotech partners.

What has remained constant is the culture we carried into listing: deep scientific commitment, disciplined client-centric ex*****on, and a clear focus on long-term value creation.

As we look ahead, we carry this momentum forward, with the same ownership, purpose, and pride that have defined our journey so far.

11/12/2025

Sai Life Sciences, along with its client Bayer, has published a case study in The Climate Drive, an open digital platform powered by the WBCSD – World Business Council for Sustainable Development that helps businesses learn and take action on their Net Zero pathways.

The case study highlights how Sai Life Sciences implemented a hybrid solar–wind power model at its flagship manufacturing site in Bidar, India, under a long-term captive power purchase agreement (PPA). Driven by a commitment to responsible operations and to advancing the sustainability goals of the programs we support, this transition increased the site’s renewable energy usage from 0% to 96% in just three years. It significantly led to reduction of Scope 2 emissions and creating a scalable model for responsible energy adoption.

You can read the full case study here: https://www.theclimatedrive.org/action-library/shift-to-renewables-from-0-to-96-in-3-years

As part of Bayer’s broader engagement on climate action, Sai Life Sciences was also recognized in the Igniting Networks Decarbonization Excellence Award 2025, reflecting the measurable progress captured in this initiative.

08/12/2025

Sai Life Sciences Limited, one of India’s fastest-growing Contract Research, Development & Manufacturing Organizations (CRDMO), will be conducting ‘Walk-in interviews’ in Mumbai on December 14, 2025, at Courtyard by Marriott, Navi Mumbai, Sector 7, Nerul, Navi Mumbai, Maharashtra.

03/12/2025

A discussion that went beyond chemistry to what truly shapes scientific excellence.

We were delighted to host Dr Santanu Mukherjee, Professor in the Department of Organic Chemistry at IISc Bangalore, at Sai Life Sciences where he joined Santosh Kulkarni for an engaging Fireside Chat.

From the importance of documenting every detail in the lab to the question of what it will take for an Indian chemist to win the Nobel Prize, the conversation opened up a candid exploration of the discipline, ambition, and ecosystem needed to push science forward.

He spoke about the global shifts shaping organic chemistry, the realities of research culture, and why rigor often matters more than brilliance.

A thoughtful, energising exchange that left our teams inspired.

28/11/2025

Every year on Children’s Day, it’s a cherished tradition at Sai to host our annual painting competition, Chitrakaar. Some years we give them a theme, some years we let imagination lead the way — but over time, a clear pattern has emerged. The children are telling us something. More and more drawings show the world they want to grow up in ... greener landscapes, pristine rivers, clear skies, cleaner cities.

Their art has become a gentle mandate — a reminder of the future they hope we will help shape. And from expanding our green energy use to strengthening water management, to enhancing waste recycling, we are making steady, meaningful strides toward the world they imagine.

27/11/2025

Our MD & CEO Krishna Kanumuri was recently interviewed by Mike Christel of Pharmaceutical Executive for a feature on next-gen CDMOs. In the interview, Krishna discusses how Indian CDMOs are evolving from tactical suppliers to strategic suppliers and how Sai Life Sciences is preparing for the new times.

27/11/2025

Our MD & CEO Krishna Kanumuri was recently interviewed by Mike Christel of Pharmaceutical Executive for a feature on next-gen CDMOs. In the interview, Krishna discusses how Indian CDMOs are evolving from tactical suppliers to strategic suppliers and how Sai Life Sciences is preparing for the new times.

Read the full interview here: https://www.pharmexec.com/view/next-gen-cdmos-keeping-pace-with-industry-change

22/11/2025

Reema Raj attended the 5th Edition of the L&D Summit & Awards, where she was part of a panel on ‘Moving from traditional training delivery to becoming a strategic partner in talent development.’

She shared insights on how L&D can drive business impact by aligning capability-building with organisational priorities. Her session also highlighted the importance of a mindset shift for L&D to transform into a ‘Business Enabler’ rather than a support function, along with data-driven learning strategies and fostering a culture of continuous development.

Sailifesciences

29/01/2026

27/01/2026

01/01/2026

19/12/2025

18/12/2025

11/12/2025

08/12/2025

03/12/2025

28/11/2025

27/11/2025

27/11/2025

22/11/2025

Address

Opening Hours

Website

Alerts

Contact The Practice

Shortcuts

Share

Category

Monday	9:15am - 6:15pm
Tuesday	9:15am - 6:15pm
Wednesday	9:15am - 6:15pm
Thursday	9:15am - 6:15pm
Friday	9:15am - 6:15pm